Antibiotic delivery by liposomes from prokaryotic microorganisms: Similia cum similis works better

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 94, Issue , 2015, Pages 411-418

  Colzi, Ilaria ^a   Troyan, Anna N ^b   Perito, Brunella ^a   Casalone, Enrico ^a   Romoli, Riccardo ^a   Pieraccini, Giuseppe ^a   Škalko Basnet, Nataša ^b   Adessi, Alessandra ^a   Rossi, Federico ^a   Gonnelli, Cristina ^a   Ristori, Sandra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Antibiotic delivery; Antimicrobial activity; Biolipids; Liposomes; Penicillin resistance

Indexed keywords

LIPOSOME; PENICILLIN G; PROKARYOTE DERIVED LIPOSOME; UNCLASSIFIED DRUG; AMPICILLIN; ANTIINFECTIVE AGENT; DRUG CARRIER; PHOSPHOLIPID;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH INHIBITION; LIPOSOMAL DELIVERY; MEMBRANE VESICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PROKARYOTE; CHEMISTRY; CYANOTHECE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PHARMACEUTICS; PROCEDURES; RHODOPSEUDOMONAS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CYANOTHECE; DRUG CARRIERS; ESCHERICHIA COLI; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; PHOSPHOLIPIDS; RHODOPSEUDOMONAS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84936752134     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.06.013     Document Type: Article

References (75)

1. H.C. Neu The crisis in antibiotic resistance Science 257 1992 1064 1073
2. H. Goossens, M. Ferech, R.V. Stichele, and M. Elseviers Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 587
3. Q. Zhang, K. Robin, D. Liao, G. Lambert, and R.H. Austin The goldilocks principle and antibiotic resistance in bacteria Mol. Pharm. 8 2011 2063 2068
4. S. Reardon Antibiotic resistance sweeping developing world Nature 509 2014 141 142
5. A.E. Mather Antibiotics and collateral damage Science 344 2014 472 473
6. WHO, Antimicrobial resistance: Global report on surveillance 2014, < http://www.who.int/drugresistance/documents/surveillancereport/en/ >.
7. J.I. Hawker, S. Smith, G.E. Smith, R. Morbey, A.P. Johnson, D.M. Fleming, L. Shallcross, and A.C. Hayward Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: analysis of a large database of primary care consultations J. Antimicrob. Chemother. 69 2014 3423 3430
8. D.J. Payne, M.N. Gwynn, D.J. Holmes, and D.L. Pompliano Drugs for bad bugs: confronting the challenges of antibacterial discovery Nat. Rev. Drug Discov. 6 2007 29 40
9. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 48 2009 1 12
10. C.T. Walsh, and T.A. Wencewicz Prospects for new antibiotics: a molecule-centered perspective J. Antib. 67 2014 7 22
11. S.E. Cosgrove The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs Clin. Infect. Dis. 42 2006 S82 S89
12. R.R. Roberts, B. Hota, I. Ahmad, R.D. Scott, S.D. Foster, F. Abbasi, S. Schabowski, L.M. Kampe, G.G. Ciavarella, M. Supino, J. Naples, R. Cordell, S.B. Levy, and R.A. Weinstein Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship Clin. Infect. Dis. 49 2009 1175 1184
13. F. Broccolo, G. Cainelli, G. Caltabiano, C.E.A. Cocuzza, C.G. Fortuna, P. Galletti, D. Giacomini, G. Musumarra, R. Musumeci, and A. Quintavalla Design, synthesis, and biological evaluation of 4-alkyliden-beta lactams: new products with promising antibiotic activity against resistant bacteria J. Med. Chem. 49 2006 2804 2811
14. S. Nath, C. Kaittanis, A. Tinkham, and J.M. Perez Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility Anal. Chem. 80 2008 1033 1038
15. A.J. Huh, and Y.J. Kwon "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era J. Control. Rel. 156 2011 128 145
16. P. Basnet, and N. Škalko-Basnet Nanodelivery systems for improved topical antimicrobial therapy Curr. Pharm. 19 2013 7237 7243
17. R. Pelgrift, and A.J. Friedman Nanotechnology as a therapeutic tool to combat microbial resistance Adv. Drug Deliv. Rev. 65 2013 1803 1815
18. H. Pinto-Alphandary, A. Andremont, and P. Couvreur Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int. J. Antimicrob. Agents 13 2000 155 168
19. I.I. Salem, D.L. Flasher, and N. Düzgüneş Liposome-encapsulated antibiotics Meth. Enzym. 391 2005 261 291
20. Z. Drulis-Kawa, and A. Dorotkiewicz-Jach Liposomes as delivery systems for antibiotics Int. J. Pharm. 387 2010 187 198
21. D. Pornpattananangkul, L. Zhang, S. Olson, S. Aryal, M. Obonyo, K. Vecchio, C.M. Huang, and L. Zhang Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the Treatment of Bacterial Infection J. Am. Chem. Soc. 133 2011 4132 4139
22. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822
23. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
24. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug. Discov. 9 2010 615 627
25. J. Shi, A.R. Votruba, O.C. Farokhzad, and R. Langer Nanotechnology in drug delivery and tissue engineering: from discovery to applications Nano Lett. 10 2010 3223 3230
26. A. Zattoni, B. Roda, F. Borghi, V. Marassi, and P. Reschiglian Flow field-flow fractionation for the analysis of nanoparticles used in drug delivery J. Pharm. Biomed. Anal. 87 2014 53 61
27. T.M. Allen, and P.M. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Del. Rev. 65 2013 36 48
28. Liposome Technology: Interactions of Liposomes with the Biological Milieu, in: G. Gregoriadis (Ed.), Liposome Technology, third ed., vol. III, CRC Press, Boca Raton, FL, 2006.
29. C. Mugabe, M. Halwani, A.O. Azghani, R.M. Lafrenie, and A. Omri Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa Antimicrob. Agents Chemother. 50 2006 2016 2022
30. G. Rukholm, C. Mugabe, A.O. Azghani, and A. Omri Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study Int. J. Antimicrob. Agents 27 2006 247 252
31. M.J. Hajipour, K.M. Fromm, A.A. Ashkarran, D. Jimenez de Aberasturi, I.R. de Larramendi, T. Rojo, V. Serpooshan, W.J. Parak, and M. Mahmoudi Antibacterial properties of nanoparticles Trends Biotechnol. 19 2012 499 511
32. K. Blecher, A. Nasir, and A. Friedman The growing role of nanotechnology in combating infectious disease Virulence 2 2011 395 401
33. C.M. Huang, C.H. Chen, D. Pornpattananangkul, L. Zhang, M. Chan, M.F. Hsieh, and L. Zhang Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids Biomaterials 32 2011 214 221
34. M.N. Jones, M. Kaszuba, M.D. Reboiras, I. Lyle, K.J. Hill, Y.H. Song, S.W. Wilmot, and J.E. Creeth The targeting of phospholipid liposomes to bacteria Biochim. Biophys. Acta, Biomem. 1196 1994 57 64
35. Y.M. Zhang, and C.O. Rock Membrane lipid homeostasis in bacteria Nature Rev., Microbiol. 6 2008 222 233
36. F. Prossnigg, A. Hickel, G. Pabst, and K. Lohne Packing behaviour of two predominant anionic phospholipids of bacterial cytoplasmic membranes Biophys. J. 150 2010 129 135
37. V. Gupta, R. Gupta, R. Grover, R. Kanna, V. Jangra, and A.J. Mittal Delivery of molecules to cancer cells using liposomes from bacterial culture J. Nanosci. Nanotech. 8 2008 2328 2333
38. A.J. Manning, and M.J. Kuehn Functional advantages conferred by extracellular prokaryotic membrane vesicles J. Mol. Microbiol. Biotechnol. 23 2013 131 141
39. M.J. Kuehn, and N.C. Kesty Bacterial outer membrane vesicles and the host-pathogen interaction Genes Dev. 19 2005 2645 2655
40. K.E. Bonnington, and M.J. Kuehn Protein selection and export via outer membrane vesicles Biochim. Biophys. Acta 1843 2014 1612 1619
41. B. Kiran, A. Kaushik, and C.P. Kaushik Metal-salt co-tolerance and metal removal by indigenous cyanobacterial strains Process Biochem. 43 2008 598 604
42. M.T. Madigan, and D.O. Jung An overview of Purple Bacteria: systematic, physiology and habitats C.N. Hunter, F. Daldal, M.C. Thurnauer, J.T. Beatty, The Purple Photrophic Bacteria 2008 Springer Dordrecht 1 15
43. R. De Philippis, M.C. Margheri, R. Materassi, and M. Vincenzini Potential of unicellular cyanobacteria from saline environments as exopolysaccharide producers Appl. Environ. Microbiol. 64 1998 1130 1132
44. R. De Philippis, C. Sili, R. Paperi, and M. Vincenzini Exopolysaccharide producing cyanobacteria and their possible exploitation: a review J. Appl. Phycol. 13 2001 293 299
45. D. Das, and T.N. Verziroglu Hydrogen production by biological processes: a survey of literature Int. J. Hydrogen Energy 26 2001 13 28
46. F.W. Larimer, P. Chain, L. Hauser, J. Lamerdin, S. Malfatti, L. Do, M.L. Land, D.A. Pelletier, J.T. Beatty, A.S. Lang, F.R. Tabita, J.L. Gibson, T.E. Hanson, C. Bobst, J.L. Torres y Torres, C. Peres, F.H. Harrison, J. Gibson, and C.S. Harwood Complete genome sequence of the metabolically versatile photosynthetic bacterium Rhodopseudomonas palustris Nat. Biotechnol. 22 2004 55 61
47. 2 sequestration on a landscape scale. IEEE Green Techn. Conf., 2012, pp. 1-3, < http://www.terraderm.org/Science/TerraDerm%20Tulsa%20Web%20Version%20Comp.pdf >.
48. M.S. Wilke, A.L. Lovering, and N.C. Strynadka Beta-lactam antibiotic resistance. a current structural perspective Curr. Opin. Microbiol. 8 2005 525 533
49. S.C. Abeylath, and E. Turos Drug delivery approaches to overcome bacterial resistance to beta-lactam antibiotics Expert Opin. Drug. Deliv. 5 2008 931 949
50. R. Mota, R. Guimaraes, Z. Buttel, F. Rossi, G. Colica, C.J. Silva, C. Santos, L. Gales, A. Zille, R. De Philippis, S.B. Pereira, and P. Tamagnini Production and characterization of extracellular carbohydrate polymer from Cyanothece sp. CCY 0110 Carbohyd. Polym. 92 2013 1408 1415
51. T.N.R. Srinivas, P. Anil Kumar, C. Sasikala, and C.V. Ramana Rhodovulum imhoffii sp. nov. Int. J. Syst. Evol. Microbiol. 57 2007 228 232
52. R. Rippka, J. Deruelles, J.B. Waterbury, M. Herdman, and R.Y. Stanier Generic assignments, strain histories and properties of pure cultures of cyanobacteria J. Gen. Microbiol. 111 1979 1 61
53. L. Bianchi, F. Mannelli, C. Viti, A. Adessi, and R. De Philippis Hydrogen-producing purple non-sulfur bacteria isolated from the trophic lake Averno (Naples, Italy) Int. J. Hydrogen Energy 35 2010 12216 12223
54. J. Norrander, T. Kempe, and J. Messing Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis Gene 26 1983 101 106
55. J.H. Miller Experiments in Molecular Genetics 1972 Cold Spring Harbor Laboratory Cold Spring Harbor, N.Y.
56. J. Folch, M. Lees, and J.H.S. Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
57. M. Axelsson, and F. Gentili A single-step method for rapid extraction of total lipids from green microalgae PLoS ONE 9 2014 e89643
58. P.S. Chen, T.Y. Toribara, and H. Warner Microdetermination of phosphorus Anal. Chem. 28 1956 1756 1758
59. G. Pabst, R. Koschuch, B. Pozo-Navas, M. Rappolt, K. Lohner, and P. Laggner Structural analysis of weakly ordered membrane stacks J. Appl. Cryst. 36 2003 1378 1388
60. G. Pabst, J. Katsaras, V.A. Raghunathan, and M. Rappolt Structure and interactions in the anomalous swelling regime of phospholipid bilayers Langmuir 19 2003 1716 1722
61. P. Wayne, National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved Standards, 4th ed., M26-A, 1999.
62. M.N. Jones, Y.H. Song, M. Kaszuba, and M.D. Reboiras The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides J. Drug Targeting 5 1997 25 34
63. M.N. Jones, Use of liposomes to deliver bactericides to bacterial biofilm, in: N. Düzagünes (Ed.), Methods in Enzymology, vol. 191, Elsevier, 2005 (Chapter 13).
64. R.A.S. Randazzo, R. Bucki, P.A. Janmey, and S.L. Diamond A series of cationic sterol lipids with gene transfer and bactericidal activity Bioorg. Med. Chem. 17 2009 3257 3265
65. Z. Drulis-Kawa, and A. Dorotkiewicz-Jach Liposomes as delivery systems for antibiotics Int. J. Pharm. 387 2010 187 198
66. S. Ristori, E. Di Cola, B. Richichi, C. Lunghi, and C. Nativi Structural study of liposomes loaded with a GM3 lactone analogue for the targeting of tumor epitopes Biochim. Biophys. Acta 1788 2009 2518 2525
67. B. Pozo-Navas, K. Lohner, G. Deutsch, E. Sevcsik, K.A. Riske, R. Dimova, P. Garidel, and G. Pabst Composition dependence of vesicle morphology and mixing properties in a bacterial model membrane system Biochim. Biophys. Acta 1716 2005 40 48
68. J.M. Pagès, C.E. James, and M. Winterhalter The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria Nat. Rev. Microbiol. 6 2008 893 903
69. A.H. Delcour Outer membrane permeability and antibiotic resistance Biochim. Biophys. Acta 1794 2009 808 816
70. N. Honoré, M.H. Nicolas, and S.T. Cole Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli EMBO J. 5 1986 3709 3714
71. B. Jaurin, T. Grundström, and S. Normark Sequence elements determining ampC promoter strength in E. coli EMBO J. 1 1982 875 881
72. M.L. Salverda, J.A. De Visser, and M. Barlow Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance FEMS Microbiol. Rev. 34 2010 1015 1036
73. T. Sawai, K. Matsuba, A. Tamura, and S. Yamagishi The bacterial outer-membrane permeability of beta-lactam antibiotics J. Antibiot. 32 1979 59 65
74. S. Kojima, and H. Nikaido Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels Proc. Natl. Acad. Sci. USA 110 2013 E2629 E2634
75. I.A. MacDonald, and M.J. Khuen Offense and defense: microbial membrane vesicles play both ways Res. Microbiol. 163 2012 607 618